Activation of this death pathway was dependent on the kinase activity of RIPK3, and required RIPK1, both of which we show are frequently expressed in serous ovarian cancer, as well as the cytokine TNFα. Here, RIPK3 is linked to ovarian serous adenocarcinoma.